Panel Session: Diversity & Inclusion in Oncology & ADC Clinical Trials
Time: 3:15 pm
day: Pre-Conference Day AM
Details:
Ensuring diversity, inclusion, and a patient centric approach in clinical trials is crucial to encompass the broad range of lived experiences and diverse populations so that all patients can benefit from the fast-paced advances and innovations in ADC therapies. Attend this brand-new session led by oncology and patient advocates to explore the significance and importance of D&I in ADC development, learn from mistakes in the past, understand the patient perspective, and hear successful case studies of implementing patient considerations in clinical trial design and recruitment to ensure your ADC product development is representative to all patient populations.
Register your interest when you sign up to attend the conference, then look out for an email to secure your spot! Highlights include:
- Exploring the current status and opportunities for improvement in D&I throughout ADC product development – what mistakes have been made in the past?
- Hearing case studies and company strategies to address and improve D&I in ADC clinical trials
- Explaining the clinical trial design and recruitment considerations from the beginning to make ADC products representative to all patient populations
- Breaking down takeaways of lived experience and incorporating learnings to help design ADC clinical trials
